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Introduction 
The aphasia literature has clearly established that treatments for aphasia are effective, 
particularly when therapy begins during the acute post-stroke recovery period and when 
provided in an intensive fashion [1-5].  Despite evidence to support the efficacy of 
aphasia treatments, only a few studies have examined service utilization [6-8], 
reimbursement [9-10], cost [11], or cost-effectiveness [12].  In 1996, Boysen and Wertz 
[12] asked, “What is a Word Worth?”  They analyzed five aphasia group efficacy studies.  
Based on $28 per hour, they estimated that therapy cost between $1,344 per patient for 
inefficacious treatment to $7,392 for efficacious treatment.  Using 15% PICA overall 
change as the effect size in two Veterans Administration cooperative studies, and 
assuming 15% overhead, the estimated personnel costs ranged from $206 to $567 for 
each percentile change (per patient).   
 
Unfortunately, subsequent studies related to the economics of aphasia treatments have 
been sparse and to some degree limited by aphasia studies that contain poorly defined 
variables (e.g. type of therapeutic interventions, frequency, duration, and extreme 
variability in intensity of interventions) necessary for realistic examinations [13-14].   
However, the current climate in healthcare nationwide suggests that regardless of the 
issues related to aphasia treatment methodologies, whether randomized group designs, 
quasi-experimental designs, or single subject experimental designs (SSE), aphasiologists 
are now required to be attentive not only to the cost and the effectiveness of aphasia 
treatment, but also to the cost effectiveness of the treatments they provide [15]. 
 
Purpose 
The purpose of this study was to examine SSE therapeutic interventions for aphasia 
presented at the Clinical Aphasiology Conference (CAC) to determine their cost 
effectiveness.  The specific aims of this preliminary investigation were to determine the 
cost, the cost effectiveness, and the marginal benefit of additional treatment sessions.  We 
report an examination of the cost and cost-effectiveness of therapeutic interventions for 
aphasia completed using SSE designs and reported in papers previous presented at CAC 
conferences.  We selected studies completed with SSE designs because they are ideally 
suited to address methodological concerns associated with the study of the costs and cost-
effectiveness of aphasia treatments [16].   
 
 
Methods and Procedures 
We previewed The Aphasiology Archive 1974-2006 (University of Pittsburgh, 2006) [17] 
and identified the empirical studies of aphasia treatment using SSE methodology.  
Inclusion criteria were: 1) poststroke aphasia, 2) single subject experimental treatment, 
and 3) English speakers only.  Exclusion criteria were: 1) non-stroke etiologies, 2) 
interventions emphasizing treatment of apraxia of speech, 3) interventions using a 
predetermined rather than criterion-based number of treatment sessions, and studies using 
hybrid SSE methodologies. 
 
Demographic and diagnostic characteristics, the number of treatment sessions, and 
baseline and outcome proficiency levels of each treated behavior were extracted from 
each qualified study. The cost-effectiveness of the interventions was determined using a 
multivariate regression.  We used a multi-level mixed-effect design with separate random 
effects for the intervention and the subject, thereby controlling for unmeasured 
differences between the interventions and subjects. See Table 1 for operational 
definitions relevant to this analysis.   
 
We measured cost-effectiveness in two ways:  
1) by calculating the average treatment effect or increase in the target treatment 
variable while ignoring the number of sessions. 
 
2) by calculating a quadratic treatment effect that allows the effect of each 
additional session to change over time.  The quadratic treatment effect was 
measured by using the coefficient on the number of treatment sessions and the 
number of treatment sessions squared.  
 
Two specifications were used for each model: 1) moderate or severe aphasia at baseline, 
and 2) patient characteristics.  We report the effect of treatment under both specifications.    
 
Results 
The results from 96 observations; aphasia interventions completed on individual subjects 
as reported in studies using SSE designs   We report baseline demographics: (age, 
education, gender, baseline aphasia severity, and aphasia chronicity in Table 2.  
Race/ethnicity, handedness, stroke number, stroke type, or post-treatment performance on 
standardized aphasia measures are not reported due to missing data.  
 
The average number of treatment sessions completed was approximately 10 for each 
aphasia intervention.  The performance proficiency for the target variables (interventions) 
before treatment averaged about 23%; after treatment, about 67%. Table 3 summarizes 
proficiency levels before and after treatment, and the number of treatment sessions 
completed to achieve the proficiency level.  For this analysis, a per session treatment cost 
of $35.53 was used.  This figure was based upon rates obtained from the Bureau of Labor 
Statistics [18-19] (Table 1).  Given an average number of sessions of 10.563 (see Table 
3), and a per session cost of $35.53, the cost of a 45% point increase in a single treated 
target behavior was: 10.563*35.53=$375.30.   This yields a cost effectiveness ratio of 
8.34:  ($375.30/45=8.34), i.e., it costs $8.34 for each 1% increase in the target behavior.   
 
To determine whether the treatment effect was larger during the first several sessions, and 
whether the beneficial effect of each additional session diminishes as the number of 
treatments increase, we analyzed the marginal effectiveness of additional treatment 
sessions.  Specification 1 controlled for pre-treatment aphasia severity; Specification 2 
controlled for patient characteristics.   
 
 
The results in Table 4 are interpreted as follows:   
(1) Since the number of sessions (6.128) is positive, we can infer that the sessions 
are effective.   
(2) However, since the coefficient associated with the squared term is negative     
(-0.161), we imply that the effectiveness of each session declines as the 
number of sessions increases.  Based on these values, it can be shown that 
maximum effectiveness occurs by 19 sessions.     
 
To estimate cost-effectiveness ratios of groups of 5 sessions up to 20 sessions, we applied 
the quadratic result in Table 4.  The first 5 sessions yielded an improvement of 18.53 
percentage points; the next 5 sessions, an improvement of 10.46 percentage points; and 
the next 5, an additional 2.38 points (See Table 5).  The final 5 sessions did not yield an 
improvement and actually may have had a negative effect.   The right column (Table 5) 
shows the CE ratio; a calculation of the cost of five sessions divided by the percentage 
improvement associated with the five sessions.  The CE ratio for the first five sessions is 
9.59.  The CE ratio increased from 9.59 to 16.99, and finally, to 74.60. Thus, it is seven 
times more expensive to facilitate a 1% change in performance in sessions 11 to 15, as 
compared to sessions 1-5.        
 
Discussion  
These findings show that treatments rendered in an SSE format yield improvement in the 
proficiency of target behaviors.  Aphasia therapy ‘works,’ but is it cost-effective? Our 
data suggest that aphasia interventions, on average, are cost effective up to 19 sessions. 
After that point, the cost effectiveness ratio increases substantially as marginal benefit 
declines.  To our knowledge, no previous study has analyzed the cost effectiveness of 
aphasia treatment that used SSE methodology. Despite the obvious appeal of SSE designs 
for demonstrating accountability, aphasiologists should be attentive not only to the 
effectiveness of SSE aphasia treatment, but also to its cost effectiveness.  Further 
investigations are needed to fully understand the value (effectiveness, cost effectiveness, 
and marginal benefit) of different types of interventions for different types of patients to 
help assure that aphasiologists select patients appropriately, match specific treatments to 
specific aphasia profiles, and use scarce healthcare dollars responsibly.    
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Table 1. Operational definitions for this study. 
 
Observation:  Each treatment (intervention) for each separate target behavior. 
Outcome (dependent variable): The difference between pre-treatment and post-
treatment performance proficiency, each calculated as the average of the 
lowest and highest datapoints in the relevant phase. 
Cost: The average professional cost was $35.53 per hour (Bureau of Labor 
Statistics, 2005, 2006).  
Cost effectiveness (CE) ratio: The cost per unit of effectiveness, in this case, a 1% 
change.  
Marginal effect: The effect of one additional unit of treatment, derived by 
comparing the amount of change across sessions using the quadratic 
equation described in the paper.    
  
 
 
 
Table 2. Sample characteristics for individuals with aphasia who engaged in single 
subject experimental treatments. 
 
 
Variable 
 
Sample Characteristics Standard Deviation 
Age (years) 
 
55.30 15.35 
Male (percentage) 
 
78.72 0.410 
Education (years) 13.03 3.178 
 
High school education (percentage) 
 
48.96 0.501 
Chronicity (months post onset) 
 
47.49 51.520 
Western Aphasia Battery (aphasia 
quotient) 
 
84.38 0.364 
Porch Index of Communicative 
Abilities (overall percentile) 
 
26.04 0.440 
Boston Diagnostic Aphasia 
Examination (overall severity) 
 
5.21 0.223 
Baseline moderate aphasia 
(percentage) 
 
71.88 0.451 
Baseline severe aphasia 
(percentage) 
 
25.00 0.434 
 
Note: Missing data for gender, race/ethnicity, handedness, stroke number and stroke type 
precluded analysis. 
 
Table 3. Proficiency levels of target behaviors before and after aphasia treatment for a 
variety of interventions using single subject experimental methodology 
 
 
Variable 
 
Sample Characteristics Standard Deviation 
Proficiency before 
treatment 
 
23.198 20.268 
Proficiency after treatment 
 
68.672 21.172 
Number of treatment 
sessions 
 
10.563 8.142 
 
Table 4. Average effect of treatment on percent change in performance proficiency level 
 
 
 Specification 1 Specification 2 
 Average Effect of Treatment Average Effect of Treatment 
 Effect S.D. Effect S.D. 
Treatment 45.474 2.186 45.652 2.510 
 Quadratic Effect of An 
Additional Session 
 
Quadratic Effect of An 
Additional Session 
 Effect S.D. Effect S.D. 
Number of sessions 6.128 0.485 5.900 0.537 
Number of sessions 
squared 
-0.161 0.018 -0.156 0.019 
 
Specification 1: Controls for baseline moderate and severe aphasia 
Specification 2: Controls for baseline moderate and severe aphasia plus indicator 
variables for male, high school education, chronicity, and baseline aphasia severity 
(WAB, PICA or BDAE) 
 
Table 5. Cost effectiveness ratios by number of treatment sessions in single subject 
experimental aphasia interventions 
 
Increasing Number of 
Sessions (Treatments) 
Improvement in Score     
(percentage points) 
 
CE Ratio 
From 1 to 5 18.53 $9.59 
From 6 to 10 10.46 $16.99 
From 11 to 15 2.38 $74.60 
From 16 to 20 -5.69 N/A 
 
 Note: The right column reflects the increasing cost for each 1% change in proficiency. 
  
 
